{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:40:16Z","timestamp":1794440416927,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21-AR071878"],"award-info":[{"award-number":["R21-AR071878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AR076948"],"award-info":[{"award-number":["R21 AR076948"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although genome-wide association studies (GWAS) have identified multiple regions conferring genetic risk for juvenile idiopathic arthritis (JIA), we are still faced with the task of identifying the single nucleotide polymorphisms (SNPs) on the disease haplotypes that exert the biological effects that confer risk. Until we identify the risk-driving variants, identifying the genes influenced by these variants, and therefore translating genetic information to improved clinical care, will remain an insurmountable task. We used a function-based approach for identifying causal variant candidates and the target genes on JIA risk haplotypes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used a massively parallel reporter assay (MPRA) in myeloid K562 cells to query the effects of 5,226 SNPs in non-coding regions on JIA risk haplotypes for their ability to alter gene expression when compared to the common allele. The assay relies on 180\u00a0bp oligonucleotide reporters (\u201coligos\u201d) in which the allele of interest is flanked by its cognate genomic sequence. Barcodes were added randomly by PCR to each oligo to achieve\u2009&gt;\u200920 barcodes per oligo to provide a quantitative read-out of gene expression for each allele. Assays were performed in both unstimulated K562 cells and cells stimulated overnight with interferon gamma (IFNg). As proof of concept, we then used CRISPRi to demonstrate the feasibility of identifying the genes regulated by enhancers harboring expression-altering SNPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 553 expression-altering SNPs in unstimulated K562 cells and an additional 490 in cells stimulated with IFNg. We further filtered the SNPs to identify those plausibly situated within functional chromatin, using open chromatin and H3K27ac ChIPseq peaks in unstimulated cells and open chromatin plus H3K4me1 in stimulated cells. These procedures yielded 42 unique SNPs (total\u2009=\u200984) for each set. Using CRISPRi, we demonstrated that enhancers harboring MPRA-screened variants in the <jats:italic>TRAF1<\/jats:italic> and <jats:italic>LNPEP\/ERAP2<\/jats:italic> loci regulated multiple genes, suggesting complex influences of disease-driving variants.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Using MPRA and CRISPRi, JIA risk haplotypes can be queried to identify plausible candidates for disease-driving variants. Once these candidate variants are identified, target genes can be identified using CRISPRi informed by the 3D chromatin structures that encompass the risk haplotypes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-024-01954-z","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:02:41Z","timestamp":1720782161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A systematic strategy for identifying causal single nucleotide polymorphisms and their target genes on Juvenile arthritis risk haplotypes"],"prefix":"10.1186","volume":"17","author":[{"given":"Kaiyu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Tewhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongkyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungki","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"1","key":"1954_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0031-3955(16)34532-1","volume":"31","author":"SL Gortmaker","year":"1984","unstructured":"Gortmaker SL, Sappenfield W. Chronic childhood disorders: prevalence and impact. Pediatr Clin North Am. 1984;31(1):3\u201318.","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"1954_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0889-857X(21)00889-9","volume":"16","author":"BH Singsen","year":"1990","unstructured":"Singsen BH. Rheumatic diseases of childhood. Rheum Dis Clin North Am. 1990;16(3):581\u201399.","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"1954_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/1529-0131(199911)42:11<2261::AID-ANR1>3.0.CO;2-P","volume":"42","author":"DN Glass","year":"1999","unstructured":"Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum. 1999;42(11):2261\u20138.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1954_CR4","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1002\/art.27516","volume":"62","author":"S Prahalad","year":"2010","unstructured":"Prahalad S, Zeft AS, Pimentel R, Clifford B, McNally B, Mineau GP, et al. Quantification of the familial contribution to juvenile idiopathic arthritis. Arthritis Rheum. 2010;62(8):2525\u20139.","journal-title":"Arthritis Rheum"},{"key":"1954_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jaut.2015.08.002","volume":"64","author":"AO Hersh","year":"2015","unstructured":"Hersh AO, Prahalad S. Immunogenetics of juvenile idiopathic arthritis: a comprehensive review. J Autoimmun. 2015;64:113\u201324.","journal-title":"J Autoimmun"},{"issue":"6","key":"1954_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ng.2614","volume":"45","author":"A Hinks","year":"2013","unstructured":"Hinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, et al. Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet. 2013;45(6):664\u20139.","journal-title":"Nat Genet"},{"issue":"11","key":"1954_CR7","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/art.40216","volume":"69","author":"LA McIntosh","year":"2017","unstructured":"McIntosh LA, Marion MC, Sudman M, Comeau ME, Becker ML, Bohnsack JF, et al. Genome-Wide Association Meta-Analysis reveals Novel Juvenile Idiopathic Arthritis susceptibility loci. Arthritis Rheumatol. 2017;69(11):2222\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"6099","key":"1954_CR8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1222794","volume":"337","author":"MT Maurano","year":"2012","unstructured":"Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337(6099):1190\u20135.","journal-title":"Science"},{"issue":"7539","key":"1954_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","volume":"518","author":"KK Farh","year":"2015","unstructured":"Farh KK, Marson A, Zhu J, Kleinewietfeld M, Housley WJ, Beik S, et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518(7539):337\u201343.","journal-title":"Nature"},{"issue":"7","key":"1954_CR10","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/art.39135","volume":"67","author":"K Jiang","year":"2015","unstructured":"Jiang K, Zhu L, Buck MJ, Chen Y, Carrier B, Liu T, et al. Disease-Associated single-nucleotide polymorphisms from noncoding regions in Juvenile Idiopathic Arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4\u2009+\u2009T cells. Arthritis Rheumatol. 2015;67(7):1966\u201377.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1954_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13075-017-1260-x","volume":"19","author":"L Zhu","year":"2017","unstructured":"Zhu L, Jiang K, Webber K, Wong L, Liu T, Chen Y, et al. Chromatin landscapes and genetic risk for juvenile idiopathic arthritis. Arthritis Res Ther. 2017;19(1):57.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1954_CR12","doi-asserted-by":"publisher","first-page":"e0235857","DOI":"10.1371\/journal.pone.0235857","volume":"15","author":"K Jiang","year":"2020","unstructured":"Jiang K, Kessler H, Park Y, Sudman M, Thompson SD, Jarvis JN. Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci. PLoS ONE. 2020;15(7):e0235857.","journal-title":"PLoS ONE"},{"issue":"6","key":"1954_CR13","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cell.2016.04.027","volume":"165","author":"R Tewhey","year":"2016","unstructured":"Tewhey R, Kotliar D, Park DS, Liu B, Winnicki S, Reilly SK, et al. Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell. 2016;165(6):1519\u201329.","journal-title":"Cell"},{"issue":"1","key":"1954_CR14","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/s41598-017-02966-9","volume":"7","author":"L Wong","year":"2017","unstructured":"Wong L, Jiang K, Chen Y, Jarvis JN. Genetic insights into juvenile idiopathic arthritis derived from deep whole genome sequencing. Sci Rep. 2017;7(1):2657.","journal-title":"Sci Rep"},{"key":"1954_CR15","doi-asserted-by":"crossref","unstructured":"Throm AA, Moncrieffe H, Orandi AB, Pingel JT, Geurs TL, Miller HL et al. Identification of enhanced IFN-gamma signaling in polyarticular juvenile idiopathic arthritis with mass cytometry. JCI Insight. 2018;3(15).","DOI":"10.1172\/jci.insight.121544"},{"issue":"1","key":"1954_CR16","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar1018","volume":"6","author":"JN Jarvis","year":"2004","unstructured":"Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P, et al. Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther. 2004;6(1):R15\u201332.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1954_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"21","key":"1954_CR18","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/hmg\/ddz216","volume":"28","author":"D Kim","year":"2019","unstructured":"Kim D, Park Y. Molecular mechanism for the multiple sclerosis risk variant rs17594362. Hum Mol Genet. 2019;28(21):3600\u20139.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1954_CR19","doi-asserted-by":"publisher","first-page":"11043","DOI":"10.1038\/s41598-019-47521-w","volume":"9","author":"D Kim","year":"2019","unstructured":"Kim D, An H, Shearer RS, Sharif M, Fan C, Choi JO, et al. A principled strategy for mapping enhancers to genes. Sci Rep. 2019;9(1):11043.","journal-title":"Sci Rep"},{"issue":"23","key":"1954_CR20","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddab184","volume":"30","author":"D Kim","year":"2021","unstructured":"Kim D, An H, Fan C, Park Y. Identifying oligodendrocyte enhancers governing Plp1 expression. Hum Mol Genet. 2021;30(23):2225\u201339.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1954_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1182\/blood-2005-05-2133","volume":"107","author":"X Huang","year":"2006","unstructured":"Huang X, Wilber AC, Bao L, Tuong D, Tolar J, Orchard PJ, et al. Stable gene transfer and expression in human primary T cells by the sleeping Beauty transposon system. Blood. 2006;107(2):483\u201391.","journal-title":"Blood"},{"key":"1954_CR22","doi-asserted-by":"crossref","unstructured":"Gasperini M, Hill AJ, McFaline-Figueroa JL, Martin B, Kim S, Zhang MD et al. A genome-wide Framework for Mapping Gene Regulation via Cellular Genetic screens. Cell. 2019;176(1\u20132):377\u2009\u2013\u200990 e19.","DOI":"10.1016\/j.cell.2018.11.029"},{"issue":"11","key":"1954_CR23","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1136\/ard.2008.089060","volume":"67","author":"HM Albers","year":"2008","unstructured":"Albers HM, Kurreeman FA, Houwing-Duistermaat JJ, Brinkman DM, Kamphuis SS, Girschick HJ, et al. The TRAF1\/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis. Ann Rheum Dis. 2008;67(11):1578\u201380.","journal-title":"Ann Rheum Dis"},{"key":"1954_CR24","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3389\/fimmu.2020.01576","volume":"11","author":"F Paladini","year":"2020","unstructured":"Paladini F, Fiorillo MT, Tedeschi V, Mattorre B, Sorrentino R. The multifaceted nature of Aminopeptidases ERAP1, ERAP2, and LNPEP: from evolution to Disease. Front Immunol. 2020;11:1576.","journal-title":"Front Immunol"},{"issue":"12","key":"1954_CR25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nmeth.3630","volume":"12","author":"PI Thakore","year":"2015","unstructured":"Thakore PI, D\u2019Ippolito AM, Song L, Safi A, Shivakumar NK, Kabadi AM, et al. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements. Nat Methods. 2015;12(12):1143\u20139.","journal-title":"Nat Methods"},{"issue":"2","key":"1954_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.celrep.2015.06.012","volume":"12","author":"JJ Breunig","year":"2015","unstructured":"Breunig JJ, Levy R, Antonuk CD, Molina J, Dutra-Clarke M, Park H, et al. Ets factors regulate neural stem cell depletion and gliogenesis in Ras Pathway Glioma. Cell Rep. 2015;12(2):258\u201371.","journal-title":"Cell Rep"},{"key":"1954_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.33590\/emjrheumatol\/10313716","volume":"1","author":"MKPM Herlin","year":"2014","unstructured":"Herlin MKPM, Herlin T. Update on genetic susceptibility and pathogenesis in juvenile idiopathic arthritis. EMJ Rheumatol. 2014;1:73\u201383.","journal-title":"EMJ Rheumatol"},{"issue":"8","key":"1954_CR28","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41588-018-0156-2","volume":"50","author":"RE Gate","year":"2018","unstructured":"Gate RE, Cheng CS, Aiden AP, Siba A, Tabaka M, Lituiev D, et al. Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Nat Genet. 2018;50(8):1140\u201350.","journal-title":"Nat Genet"},{"issue":"6","key":"1954_CR29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1101\/gr.133546.111","volume":"22","author":"RY Birnbaum","year":"2012","unstructured":"Birnbaum RY, Clowney EJ, Agamy O, Kim MJ, Zhao J, Yamanaka T, et al. Coding exons function as tissue-specific enhancers of nearby genes. Genome Res. 2012;22(6):1059\u201368.","journal-title":"Genome Res"},{"issue":"1","key":"1954_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-016-0277-0","volume":"8","author":"N Ahituv","year":"2016","unstructured":"Ahituv N. Exonic enhancers: proceed with caution in exome and genome sequencing studies. Genome Med. 2016;8(1):14.","journal-title":"Genome Med"},{"issue":"1","key":"1954_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13059-018-1519-9","volume":"19","author":"Y Wang","year":"2018","unstructured":"Wang Y, Song F, Zhang B, Zhang L, Xu J, Kuang D, et al. The 3D genome browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 2018;19(1):151.","journal-title":"Genome Biol"},{"issue":"7","key":"1954_CR32","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SS Rao","year":"2014","unstructured":"Rao SS, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159(7):1665\u201380.","journal-title":"Cell"},{"key":"1954_CR33","doi-asserted-by":"crossref","unstructured":"Kim-Hellmuth S, Aguet F, Oliva M, Munoz-Aguirre M, Kasela S, Wucher V et al. Cell type-specific genetic regulation of gene expression across human tissues. Science. 2020;369(6509).","DOI":"10.1101\/806117"},{"issue":"5","key":"1954_CR34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ajhg.2018.04.002","volume":"102","author":"MD Gallagher","year":"2018","unstructured":"Gallagher MD, Chen-Plotkin AS. The Post-GWAS era: from association to function. Am J Hum Genet. 2018;102(5):717\u201330.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1954_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13073-021-00857-3","volume":"13","author":"S Rao","year":"2021","unstructured":"Rao S, Yao Y, Bauer DE. Editing GWAS: experimental approaches to dissect and exploit disease-associated genetic variation. Genome Med. 2021;13(1):41.","journal-title":"Genome Med"},{"issue":"1","key":"1954_CR36","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41467-021-21854-5","volume":"12","author":"X Lu","year":"2021","unstructured":"Lu X, Chen X, Forney C, Donmez O, Miller D, Parameswaran S, et al. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat Commun. 2021;12(1):1611.","journal-title":"Nat Commun"},{"issue":"1","key":"1954_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13075-016-1169-9","volume":"18","author":"JS Hui-Yuen","year":"2016","unstructured":"Hui-Yuen JS, Zhu L, Wong LP, Jiang K, Chen Y, Liu T, et al. Chromatin landscapes and genetic risk in systemic lupus. Arthritis Res Ther. 2016;18(1):281.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1954_CR38","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s41467-020-15022-4","volume":"11","author":"JP Ray","year":"2020","unstructured":"Ray JP, de Boer CG, Fulco CP, Lareau CA, Kanai M, Ulirsch JC, et al. Prioritizing disease and trait causal variants at the TNFAIP3 locus using functional and genomic features. Nat Commun. 2020;11(1):1237.","journal-title":"Nat Commun"},{"issue":"5","key":"1954_CR39","doi-asserted-by":"publisher","first-page":"e12112","DOI":"10.15252\/emmm.202012112","volume":"12","author":"C Bourges","year":"2020","unstructured":"Bourges C, Groff AF, Burren OS, Gerhardinger C, Mattioli K, Hutchinson A, et al. Resolving mechanisms of immune-mediated disease in primary CD4 T cells. EMBO Mol Med. 2020;12(5):e12112.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1954_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1101\/gr.212092.116","volume":"27","author":"F Inoue","year":"2017","unstructured":"Inoue F, Kircher M, Martin B, Cooper GM, Witten DM, McManus MT, et al. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity. Genome Res. 2017;27(1):38\u201352.","journal-title":"Genome Res"},{"issue":"20","key":"1954_CR41","doi-asserted-by":"publisher","first-page":"11304","DOI":"10.1093\/nar\/gkaa877","volume":"48","author":"HC Ainsworth","year":"2020","unstructured":"Ainsworth HC, Howard TD, Langefeld CD. Intrinsic DNA topology as a prioritization metric in genomic fine-mapping studies. Nucleic Acids Res. 2020;48(20):11304\u201321.","journal-title":"Nucleic Acids Res"},{"key":"1954_CR42","doi-asserted-by":"publisher","first-page":"29477","DOI":"10.1038\/srep29477","volume":"6","author":"L Wong","year":"2016","unstructured":"Wong L, Jiang K, Chen Y, Hennon T, Holmes L, Wallace CA, et al. Limits of Peripheral Blood mononuclear cells for gene expression-based biomarkers in Juvenile Idiopathic Arthritis. Sci Rep. 2016;6:29477.","journal-title":"Sci Rep"},{"key":"1954_CR43","doi-asserted-by":"crossref","unstructured":"Wu CY, Yang HY, Huang JL, Lai JH. Signals and mechanisms regulating monocyte and macrophage activation in the pathogenesis of Juvenile Idiopathic Arthritis. Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22157960"},{"issue":"3","key":"1954_CR44","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/cmi.2015.97","volume":"13","author":"Z Zhou","year":"2016","unstructured":"Zhou Z, Xu MJ, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol Immunol. 2016;13(3):301\u201315.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1954_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13075-016-1059-1","volume":"18","author":"K Jiang","year":"2016","unstructured":"Jiang K, Wong L, Sawle AD, Frank MB, Chen Y, Wallace CA, et al. Whole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritis. Arthritis Res Ther. 2016;18(1):157.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1954_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1002\/art.38341","volume":"66","author":"K Jiang","year":"2014","unstructured":"Jiang K, Sawle AD, Frank MB, Chen Y, Wallace CA, Jarvis JN. Whole blood gene expression profiling predicts therapeutic response at six months in patients with polyarticular juvenile idiopathic arthritis. Arthritis Rheumatol. 2014;66(5):1363\u201371.","journal-title":"Arthritis Rheumatol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01954-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-024-01954-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-024-01954-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T11:04:25Z","timestamp":1720782265000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-024-01954-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1186\/s12920-024-01954-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}